| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/07/2007 | CN1298736C Method for separating purified immuno regulation active polypeptide from placenta of cattle |
| 02/07/2007 | CN1298733C Production of soluble keratin derivatives |
| 02/07/2007 | CN1298729C Modular peptide-based reagent |
| 02/06/2007 | US7173120 Regulatory sequences for regulation of gene expression in plants and other organisms, and compositions, products and methods related thereto |
| 02/06/2007 | US7173119 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173117 Codon optimised recombinant Dermaphagoides allergens |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173111 Detecting human infant kidney tumor; genetic engineered polypeptide |
| 02/06/2007 | US7173109 Peptide sequence derived from the ghrelin polypeptide, coupled to a cystine amino acid, labeled with a fluorescent dye; used in high throughput screening to identify and characterize cellular receptors |
| 02/06/2007 | US7173108 Comprises tyrosine phosphatase peptides for diagnosis, prevention and treatment of autoimmune diseases; immunotherapy |
| 02/06/2007 | US7173106 Potent and highly specific insecticidal toxin comprising 45 residues and three intramolecular disulfide bonds; method for selecting potent inhibitors of insect calcium channels |
| 02/06/2007 | US7173105 Expression vector coding a transcriptional activator protein for use animal feeds, human therapeutics and generation of preferential amino acids; fermentation |
| 02/06/2007 | US7173010 Orphanin FQ receptor |
| 02/06/2007 | US7173009 Surfactant protein C esters |
| 02/06/2007 | US7173008 Lyophilized HGF preparations |
| 02/06/2007 | US7173005 Insulin and IGF-1 receptor agonists and antagonists |
| 02/06/2007 | US7173003 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 02/06/2007 | US7173002 Identifying modulator of transforming growth factor binding for use in treatment and prevention of abnormal wound healing and cell cell proliferative disorders |
| 02/06/2007 | US7172999 Using carbohydrates or zwitterions |
| 02/06/2007 | US7172901 Isolated nucleic acid fragments encoding scorpion toxins that are potassium channel agonists; recombinant DNA constructs, transgenic cells, and viruses |
| 02/06/2007 | US7172899 A recombinant mammalian cell that expresses a mammalian adenovirus E1 functional protein and comprises a porcine circovirus genome |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172880 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them |
| 02/06/2007 | US7172876 Method of screening therapeutic agents for nerve degeneration associated diseases |
| 02/06/2007 | US7172870 Treatment of papillomavirus infections |
| 02/06/2007 | US7172867 Methods of testing for allergic diseases, and therapeutic agents for treating same |
| 02/06/2007 | US7172768 Storage stable powder compositions of interleukin-4 receptor |
| 02/06/2007 | US7172764 Rescue agents for treating botulinum toxin intoxications |
| 02/06/2007 | US7172761 Polyvalent immunogen |
| 02/06/2007 | US7172757 Method of treating fibroproliferative disorders |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2389742C Plant photoperiod sensitivity gene and use of the same |
| 02/06/2007 | CA2349594C Cells for the production of helper dependent adenoviral vectors |
| 02/06/2007 | CA2274146C Genetic modification of primate hemopoietic repopulating stem cells |
| 02/06/2007 | CA2241367C Vector for expression of n-terminally extended proteins in yeast cell |
| 02/06/2007 | CA2171557C A secretion sequence for the production of a heterologous protein in yeast |
| 02/06/2007 | CA2166479C Density enhanced protein tyrosine phosphatases |
| 02/01/2007 | WO2007014391A2 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 02/01/2007 | WO2007014382A1 Compositions and methods of mutant nogo-66 domain proteins |
| 02/01/2007 | WO2007014258A2 Growth hormone secretagogues |
| 02/01/2007 | WO2007014244A2 Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile |
| 02/01/2007 | WO2007014170A2 Compositions and methods for protein deaggregation |
| 02/01/2007 | WO2007014123A2 Compositions and methods of treating disease with fgfr fusion proteins |
| 02/01/2007 | WO2007013807A2 Targeting-enhanced activation of galectins |
| 02/01/2007 | WO2007013793A1 Sensitization of immune system against haptenized melanoma antigens |
| 02/01/2007 | WO2007013603A1 Lymphangiogenesis promoter |
| 02/01/2007 | WO2007013593A1 Method for diagnosis of gastric cancer utilizing methylation of novel gene acmg1 as index |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013574A1 Compositions and methods for treating breast cancer |
| 02/01/2007 | WO2007013438A1 Anti-obesity agent and anti-obesity food |
| 02/01/2007 | WO2007013391A1 Interferon-inducible molecule ips-1 |
| 02/01/2007 | WO2007013358A2 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 02/01/2007 | WO2007012944A2 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 02/01/2007 | WO2007012329A2 Rna-dependent rna-polymerase, methods and kits for amplifying and/or marking rna |
| 02/01/2007 | WO2007012277A1 Isolated proteins from a traditional chinese medicine yuzhu and use thereof |
| 02/01/2007 | WO2006132605A3 Porcine circovirus type 2 vaccines |
| 02/01/2007 | WO2006132530A3 Methods and means for use in diagnostics and treatment of diabetes |
| 02/01/2007 | WO2006131586B1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/01/2007 | WO2006129085A3 High affinity melan-a t cell receptors |
| 02/01/2007 | WO2006128921A3 Means and methods to modulate flavonoid biosynthesis in plants and plant cells |
| 02/01/2007 | WO2006128573A3 Ce43- 67b, insecticidal transgenic cotton expressing cry1ab |
| 02/01/2007 | WO2006128571A3 Ce44-69d , insecticidal transgenic cotton expressing cry1ab |
| 02/01/2007 | WO2006128569A3 1143-14a, insecticidal transgenic cotton expressing cry1ab |
| 02/01/2007 | WO2006128568A3 T342-142, insecticidal transgenic cotton expressing cry1ab |
| 02/01/2007 | WO2006125962A3 T cell receptors which specifically bind to vygfvracl-hla-a24 |
| 02/01/2007 | WO2006118617A3 EXPRESSING TGF-β PROTEINS IN PLANT PLASTIDS |
| 02/01/2007 | WO2006114286A3 Production of albumin-fluorescein conjugates for use in intraoperative diagnosis |
| 02/01/2007 | WO2006103101A3 MEANS FOR THE INHIBITION OF ANTI-β1-ADRENERGIC RECEPTOR ANTIBODIES |
| 02/01/2007 | WO2006099006A3 Recombinant e-selectin made in insect cells |
| 02/01/2007 | WO2006094722A3 Growth factor mutants with improved biological activity |
| 02/01/2007 | WO2006091517A3 Immunogens from uropathogenic escherichia coli |
| 02/01/2007 | WO2006089023A3 Pharmaceutical compositions for treating or preventing bone conditions |
| 02/01/2007 | WO2006082406A3 Human antibodies and proteins |
| 02/01/2007 | WO2006081249A3 Conjugates of biologically active proteins having a modified in vivo half-life |
| 02/01/2007 | WO2006076504A3 Sialic acid permease system |
| 02/01/2007 | WO2006069262A3 Compositions of influenza viral proteins and methods of use thereof |
| 02/01/2007 | WO2006066024A3 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 02/01/2007 | WO2006053788A3 Alterations in seborrheic keratoses and their applications |
| 02/01/2007 | WO2006049983A3 Peptide yy modified transferrin fusion proteins |
| 02/01/2007 | WO2006034106A3 Baff variants and methods therof |
| 02/01/2007 | WO2006029094A3 Erythropoietin derivatives with altered immunogenicity |
| 02/01/2007 | WO2006012644A3 Use of il-28 and il-29 to treat cancer |
| 02/01/2007 | WO2006004868A3 Bioactive peptide coatings |
| 02/01/2007 | WO2005118622A3 Naturally processed measles virus peptides eluted from class ii hla molecules |
| 02/01/2007 | WO2005116258A3 Influenza hemagglutinin and neuraminidase varians |
| 02/01/2007 | WO2005105837A3 Use of the ribosomal protein rpl41 to treat infections and inhibit cancer |
| 02/01/2007 | WO2005069854A3 Methods and materials relating to novel c1q domain-containing polypeptides and polynucleotides |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | WO2004067709A3 Identification of essential genes of aspergillus fumigatus and methods of use |
| 02/01/2007 | WO2004058088A8 Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries |
| 02/01/2007 | WO2004024869A3 Cancer associated antigens, sga-56m and sga-56mv, and uses thereof |
| 02/01/2007 | WO2003105773A3 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: |
| 02/01/2007 | WO2003058203A3 Extended glucagon-like peptide-1 analogs |
| 02/01/2007 | US20070028327 DNA sequence that codes for proteins involved in development of the embryo and/or endosperm, determination of seed size and/or quality, cell growth, sugar or fatty acid metabolism, nutrient transfer, of a toxic protein, a transcription inhibiting protein and a protein improving resistance to diseases |
| 02/01/2007 | US20070028324 Bacillus thuringiensis insecticidal proteins |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070028314 Bone and/or joint disease-associated genes |
| 02/01/2007 | US20070028311 Therapeutic and diagnostic means for papillomas and other diseases involving ped/pea-15 |
| 02/01/2007 | US20070027309 Nucleic acid and amino acid sequences relating to Candida albicans for diagnostics and therapeutics |